RxDoctor Payments Data

Anthony Mancini

Pediatrics · Chicago, ILNPI 1639147002

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $121,483 of the $187,485 with a category attached, or 64.8%. 22 manufacturers reported payments, led by Parapro, LLC at 39.2% of the total. Reporting peaked in 2024 at $65,556 and has fallen 99.1% since, to $610 in 2025. Among pediatrics clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$187,485in general payments, 2019–2025

Across 140 payments — averaging $1339.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Parapro, LLC$73K
  • Verrica Pharmaceuticals Inc.$41K
  • Novartis$19K
  • Dermavant Sciences, Inc.$17K
  • Galderma Laboratories, L.p.$8K
  • Sanofi$8K
  • plus $22K from 16 others

What the payments were for

  • Consulting fees$55,63830%
  • Speaking & faculty fees$121,48365%
  • Grants$5,0003%
  • Travel & lodging$1,5511%
  • Food & beverage$3,7202%
  • Education$300%
  • Gifts$620%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$187,485 in reported general payments places this provider in the 95th percentile of 2,058 pediatrics providers in Illinois.

See all pediatrics providers in Illinois

Other pediatrics in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →